No verified biotechnology news from the last 24 hours was provided in the search results, so I cannot responsibly write a real-events market analysis without source support.

The trending topics listed—FDA drug decisions, late-stage cancer therapy trial readouts, and biotech merger activity—are all highly relevant to biotechnology and pharma markets, but the absence of current verified reporting means any article would require unsupported speculation. Please provide recent source material or enable live search results, and I can produce a fully sourced institutional-style analysis immediately.